F-group (family)
298.1.1.2 Homoserine_dh
Ligands and drugs
160
Member domains
46
with ligand contacts (≤ 4 Å)
28.8% of members
51
with DrugDomain annotations
31.9% of members
45
with a DrugBank compound
28.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 298.1.1.2 belongs to X-group 298 FwdE/GAPDH domain-like, which binds 8.0 ligand superclasses per 20 proteins, broader than 56% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04193 | HSE | L-Homoserine | 11 |
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 10 |
| DB02338 | NDP | NADPH | 7 |
| DB02219 | CXS | 3-(cyclohexylamino)propanesulfonic acid | 5 |
| DB00123 | LYS | Lysine | 2 |
| DB02881 | 178 | 4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol | 2 |
| DB14128 | NAD | Nadide | 2 |
| DB02349 | NHO | Nicotinamide-adenine-dinucleotide-5-hydroxy-4-oxonorvaline | 1 |
| DB03797 | NDA | 3-Aminomethyl-Pyridinium-Adenine-Dinucleotide | 1 |
| DB09459 | TLA | L-tartaric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 16 |
| HSE | L-HOMOSERINE | 11 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 10 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 7 |
| CXS | 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID | 5 |
| MGmetal | MAGNESIUM ION | 4 |
| 178 | 4-(4-HYDROXY-3-ISOPROPYLPHENYLTHIO)-2-ISOPROPYLPHENOL | 2 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 2 |
| 80F | (2R)-3-[[(4S)-3-aminocarbonyl-1-[(2R,3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]-4H-pyridin-4-yl]sulfanyl]-2-azanyl-propanoic acid | 1 |
| LYS | LYSINE | 1 |
| NDA | 3-AMINOMETHYL-PYRIDINIUM-ADENINE-DINUCLEOTIDE | 1 |
| NHO | NICOTINAMIDE-ADENINE-DINUCLEOTIDE-5-HYDROXY-4-OXONORVALINE | 1 |